E
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A33.9 KBEidos Therapeutics, Inc.Jan 26, 9:00 AM ET·0001193125-21-017128
- 8-K381.3 KBEidos Therapeutics, Inc.Jan 26, 8:46 AM ET·0001193125-21-017109
- 8-K208.2 KBEidos Therapeutics, Inc.Jan 20, 4:23 PM ET·0001193125-21-012447
- 8-K529.4 KBEidos Therapeutics, Inc.Jan 12, 7:31 AM ET·0001193125-21-006784
- 10-Q9.7 MBEidos Therapeutics, Inc.Oct 29, 4:38 PM ET·0001564590-20-048909
- 8-K594.2 KBEidos Therapeutics, Inc.Oct 29, 4:30 PM ET·0001564590-20-048894
- SC 13D/A67.2 KBEidos Therapeutics, Inc.Oct 7, 5:00 PM ET·0001104659-20-113116
- 8-K976.7 KBEidos Therapeutics, Inc.Oct 6, 9:35 PM ET·0001193125-20-264980
- SC 13D/A557.9 KBEidos Therapeutics, Inc.Oct 5, 5:30 PM ET·0001193125-20-264026
- 8-K212.6 KBEidos Therapeutics, Inc.Oct 5, 4:06 PM ET·0001193125-20-263868
Insiders
10Tickers
No tickers on record
Addresses
business
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO, CA, 94104
mailing
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO, CA, 94104